ARCHIVES

Working Group to Look At Guidelines, Mandates, Centers Role In Prevention, Cancer Control

This article is from The Cancer Letter archive.

Vol. 10 No. 07 | February 17, 1984

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

FDA Committee to Discuss Policy On Combinations

January 7, 1977

NCI-Approved Trials Listed

March 30, 2007

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014

Cancer Patient Medical history System Proposed

July 13, 1979